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SummaryStomach-type claudin-18 (*stCldn18*) deficiency induced gastric tumorigenesis in mice without *H pylori* infection. Several signaling networks, including the cytokine-, stemness-, and Wnt signaling pathways, may be activated under the *stCldn18*-deficiency--induced chronic active gastritis to accelerate the gastric tumorigenesis.

Accumulating evidence indicates that the tissue microenvironment plays critical roles in pathophysiological processes including tumor or cancer formation.[@bib1], [@bib2], [@bib3] Recent studies suggest that tumor or cancer microenvironments contain immune or nonimmune tumor-related cellular components, extracellular matrix, and interstitial components, which are enclosed by epithelial cell sheets endowed with permselective transcellular and paracellular barrier functions.[@bib4], [@bib5], [@bib6] While the epithelial transcellular barrier functions are defined by characteristics of the epithelial cells themselves, such as their plasma membranes and transporters or channels, the paracellular barrier functions are defined by the tight junctions (TJs) between the cells.[@bib7], [@bib8], [@bib9]

*Heliobacter pylori* infection is a well-known risk factor for human gastritis and gastric cancer.[@bib10] *H pylori* infects the stomach epithelia and induces gastritis, in which epithelial cell hyperproliferation and dedifferentiation are induced by the CagA-SHP2-MAPK and *Wnt* signaling pathways.[@bib11], [@bib12] These signaling pathways are thought to be critical causes of gastric carcinogenesis.[@bib11], [@bib12] On the other hand, epithelial cell polarity and the cell-cell adhesion system including TJs are also dysregulated, through the CagA-PAR1 interaction.[@bib13] Thus, a disruption of the TJs' paracellular barrier function, which is thought to cause gastric material including H^+^ to leak into the submucosal space, might be another important factor contributing to the progression of gastritis and gastric cancer.[@bib14] However, the contribution of the paracellular barrier dysfunction of TJs to gastric pathologies has not been well analyzed.

Claudins (*Cldns*), the 4-transmembrane domain proteins of TJs, are indispensable for TJ formation.[@bib7], [@bib15], [@bib16] Recent studies revealed that a lack of specific claudins causes inflammation-related pathological conditions.[@bib17], [@bib18], [@bib19], [@bib20], [@bib21] These conditions mainly result from aberrant microenvironments generated by the inappropriate passage of water, ions, or small solutes through dysregulated TJs.[@bib8], [@bib22], [@bib23]

The expression of stomach-type *Cldn18*, a predominant and essential *Cldn* for gastric TJs, is generally decreased in various types of human gastritis and gastric cancer, with or without *H pylori* infection.[@bib14] Recently, a *Cldn18-ARHGAP* fusion gene that disturbs the paracellular barrier function of TJs was also reported in human gastric cancer.[@bib24] Furthermore, we previously reported that stomach-type *Cldn18* gene-knockout (*stCldn18--/--*) mice show acute oxyntic atrophic gastritis at a young age, induced by gastric acid (H^+^) leakage from the gastric lumen to the submucosal space through *stCldn18--/--* TJs.[@bib14], [@bib25] While it is generally accepted that tumor or cancer microenvironments can be created under chronic inflammatory conditions,[@bib26] it remains unknown whether gastric tumorigenesis or carcinogenesis can also be induced after a long period of *stCldn18-*deficiency*--*induced gastritis. Consistent with a recent report analyzing *stCldn18--/--* mice, here we independently revealed that gastric tumors developed in aged *stCldn18*--/-- mice even without *H pylori* infection.[@bib27] Furthermore, we found that several signaling networks, including the cytokine-, stemness-, and Wnt-signaling pathways, may be activated under the *stCldn18*-deficiency--induced chronic active gastritis to accelerate the gastric tumorigenesis.

Results {#sec1}
=======

Induction of Oxyntic Atrophic Gastritis in Young *stCldn18--/--* Mice and Gastric Tumor Development in Aged *stCldn18--/--* Mice {#sec1.1}
--------------------------------------------------------------------------------------------------------------------------------

To examine the long-term effects of the *stCldn18* deficiency on the gastric pathology, we analyzed *stCldn18--/--* mice at 8, 40, 60, and 100 weeks old (w.o.) ([Figure 1](#fig1){ref-type="fig"}*A* and *B*). We previously reported that *stCldn18--/--* mice exhibit oxyntic atrophic gastritis induced by gastric acid leakage from the gastric lumen into the submucosal space at a young age (\<8 w.o.).[@bib14] The obvious histological finding in the *stCldn18--/--* mouse stomach was pseudopyloric metaplasia.[@bib14] In this study, we further found that gastric tumors developed in 20%--30% of the *stCldn18--/--* mice at older ages (\>60 w.o.) ([Figure 1](#fig1){ref-type="fig"}*A* and *B*). As the gastric tumors did not appear in middle-aged *stCldn18--/--* mice (40 w.o.) ([Figure 1](#fig1){ref-type="fig"}*A* and *B*), the tumorigenic event might occur between the ages of 40 and 60 w.o.Figure 1**Induction of oxyntic atrophic gastritis in young *stCldn18--/--* mice, and gastric tumor development in aged *stCldn18--/--* mice.** (*A*) Macroscopic images of the stomach from *stCldn18+/+* (100 w.o.) and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). In the old *stCldn18--/--* mice (60, and 100 w.o.), gastric tumors and thick mucus were observed. Representative images from at least 3 independent experiments are shown. Scale bars = 1 cm. (*B*) Hematoxylin and eosin--stained low- and high-magnification images of the stomach from *stCldn18+/+* (100 w.o.) and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 50 μm, respectively.

Irregular Differentiation and Proliferation of Gastric Epithelial Cells in Young and Aged *stCldn18--/--* Mice {#sec1.2}
--------------------------------------------------------------------------------------------------------------

As gastric hyperplasia developed in the *stCldn18--/--* mice (\>40 w.o.) ([Figure 1](#fig1){ref-type="fig"}*B*), we examined the age-dependent changes in the differentiation and proliferation of gastric epithelial cells. The number of H,K-ATPase--positive parietal cells was decreased in the *stCldn18--/--* mice at all ages ([Figure 2](#fig2){ref-type="fig"}*A*). Ki-67--positive proliferative cells were observed in the bottom region of the gastric glands in the young *stCldn18--/--* mouse stomach (8 w.o.) ([Figure 2](#fig2){ref-type="fig"}*B*). The width of the proliferative zone was increased in the middle-aged *stCldn18--/--* mouse stomach (40 w.o.), and the Ki-67--positive proliferative cells became sparser in the old *stCldn18--/--* mouse stomach (\>60 w.o.) ([Figure 2](#fig2){ref-type="fig"}*B*). In contrast, the Ki-67--positive proliferative cells were located only in the neck region of the gastric glands in the *stCldn18+/+* mice at all ages ([Figure 2](#fig2){ref-type="fig"}*B*). These results suggested that in the *stCldn18--/--* mice, oxyntic atrophic gastritis with abnormal cell differentiation and proliferation occurred at all ages.Figure 2**Irregular differentiation and proliferation of gastric epithelial cells in young and aged *stCldn18--/--* mice.** (*A*) Immunohistological micrographs for H,K-ATPase as a parietal cell marker in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). The number of parietal cells was decreased in the *stCldn18--/--* mice at all ages. Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm. (*B*) Immunohistological micrographs for Ki-67 as a cell proliferation marker in the stomach from *stCldn18+/+* mice and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm.

Transition From Active to Chronic Active Gastritis in Middle-Aged *stCldn18--/--* Mice {#sec1.3}
--------------------------------------------------------------------------------------

It is generally accepted that tumor microenvironments can be created under chronic inflammatory conditions.[@bib26] In the young *stCldn18--/--* mice (8 w.o.), Gr1-positive neutrophils predominantly infiltrated the stomach ([Figure 3](#fig3){ref-type="fig"}*A* and *B*), and only low numbers of CD3^+^ T lymphocytes were observed ([Figure 3](#fig3){ref-type="fig"}*C*), suggesting that acute but not chronic gastritis was present. However, infiltrating CD3^+^ T lymphocytes were observed in the vicinity of the gastric glands in the stomach of *stCldn18*--/-- mice from middle age (\>40 w.o.) ([Figure 3](#fig3){ref-type="fig"}*C*). Consistent with this result, the number of infiltrating CD4^+^, and CD8^+^ T lymphocytes was increased in the stomach of *stCldn18*--/-- mice from middle age (\>40 w.o.) ([Figure 3](#fig3){ref-type="fig"}*D*). Gr1-positive-neutrophils were continuously detected in the stomach of *stCldn18--/--* mice from middle age (\>40 w.o.) ([Figure 3](#fig3){ref-type="fig"}*A* and *B*), similar to *H pylori* infection--related gastritis.[@bib28] These data indicated that in the *stCldn18--/--* mice, active gastritis transitioned to chronic active gastritis between youth and middle age.Figure 3**Transition from active to chronic active gastritis in middle-aged *stCldn18--/--* mice.** (*A*) Immunofluorescence micrographs for Gr-1 (*green*) as a neutrophil marker co-stained with actin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). Gr-1--positive neutrophils (*arrows*) were clearly observed in the *stCldn18--/--* mice. Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm. (*B*) (*Left*) Fluorescence-activated cell sorting (FACS) data for Ly-6G--positive neutrophils in the stomach from *stCldn18+/+* (*top*) and *stCldn18--/--* (*bottom*) mice (8, 40, 60, and 100 w.o.) (n = 8/group). The number of Ly-6G--positive neutrophils was increased in the *stCldn18--/--* mice at all ages (8, 40, 60, and 100 w.o.). (*Right*) Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\**P \<* .01; \*\*\**P \<* .001. (*C*) Immunofluorescence micrographs for CD3 as a lymphocyte marker co-stained with actin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* mice and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). CD3-positive T lymphocytes (*arrows*) were clearly observed in the stomach of *stCldn18--/--* mice only after middle-age (40, 60, and 100 w.o.). Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm. (*D*) Fluorescence-activated cell sorting (FACS) data for CD4-positive and CD8-positive T lymphocytes in the stomach from *stCldn18+/+* (*top*) and *stCldn18--/--* (*bottom*) mice (8, 40, 60, and 100 w.o.) (n = 8/group). The numbers of CD4-positive and CD8-positive T lymphocytes were increased in the *stCldn18--/--* mice only after middle-age (40, 60, 100 w.o.). (*E*) Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\**P \<* .01.

Activation of Inflammatory Signaling including CCL28 and CXCL5 in Middle-Aged *stCldn18--/--* Mice {#sec1.4}
--------------------------------------------------------------------------------------------------

As active gastritis transitioned to chronic active gastritis in the *stCldn18--/--* mice with age, we further analyzed the inflammatory signaling associated with the gastritis and the gastric tumorigenesis. The expression levels of general inflammatory cytokines such as interleukin (IL)-1β, tumor necrosis factor alpha (TNF-α), and CXCL1 were upregulated in the stomach of *stCldn18--/--* mice ([Figure 4](#fig4){ref-type="fig"}*A*).Figure 4**Activation of inflammatory signals including CCL28 and CXCL5 in aged *stCldn18--/--* mice.** (*A*) Expression levels of IL-1β, TNF-α, and CXCL1 in the stomach from *stCldn18+/+* (n = 8, 4, 11, 10) and *stCldn18--/--* mice (n = 14, 4, 13, 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\**P \<* .01. (*B*) Immunofluorescence micrographs for CXCL5 (*green*) co-stained with α-catenin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* mice and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). CXCL5 signals were clearly observed in the stomach of *stCldn18--/--* mice after middle-age (40, 60, and 100 w.o.) (*arrows*). High-magnification images are shown in insets. Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 10 μm. (*Right*) Expression level of CXCL5 in the stomach from *stCldn18+/+* (n = 8, 4, 12, 10) and *stCldn18--/--* mice (n = 6, 4, 13 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \*\**P \<* .01. (*C*) Expression levels of STAT3, IKKβ, and NF-κB in the stomach from *stCldn18+/+* (n = 4, 4, 10, 10) and *stCldn18--/--* mice (n = 6, 4, 12, 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\**P \<* .01. (*D*) (*Left*) Immunofluorescence micrographs for CCL28 (*green*), a lymphocyte chemoattractant and maintainer of chronic inflammation, co-stained with α-catenin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (10, 40, 60, and 100 w.o.). CCL28 signals were clearly observed in the stomach of the *stCldn18--/--* mice after middle-age (40, 60, and 100 w.o.) (*arrows*). High-magnification images are shown in insets. Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 10 μm. (*Right*) Expression level of CCL28 in the stomach from *stCldn18+/+* (n = 8, 4, 12, 10) and *stCldn18--/--* (n = 10, 4, 13 16) mice (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \*\**P \<* .01. (*E*) Expression levels of CXCL5, IKKβ, NFκB, and ASCL2 in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (around 50 w.o.) after POL7085 or cimetidine treatment, quantified by qRT-PCR (n: *stCldn18--/--* = 7, 5, 6, given saline, POL7085, and cimetidine, respectively). Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\**P \<* .01.

In *H pylori* infection--related gastritis and gastric cancer, some cytokines are reported to be related to the disease severity or survival rate.[@bib29], [@bib30], [@bib31], [@bib32] Among them, CXCL5, a multi-functional cytokine with neutrophil-attracting, angiogenic, and epithelial-mesenchymal transition (EMT)--inducing activities, is related to the severity of *H pylori* infection--related human gastric cancer.[@bib33], [@bib34], [@bib35] We observed CXCL5-positive gastric epithelial cells in the *stCldn18--/--* mice from middle age (\>40 w.o.) ([Figure 4](#fig4){ref-type="fig"}*B*). Consistent with this finding, the expression level of CXCL5 was significantly increased in the stomach of *stCldn18--/--* mice at old ages (\>60 w.o.) ([Figure 4](#fig4){ref-type="fig"}*B*).

The expression levels of other inflammation-related genes, including STAT3, IKKβ, and NFκB, were also upregulated in the stomach of *stCldn18--/--* mice ([Figure 4](#fig4){ref-type="fig"}*C*). IKKβ/NF-κB activation and STAT3 activation are known to have tumorigenic roles, such as in hyperproliferation, antiapoptosis, and angiogenesis.[@bib36], [@bib37], [@bib38], [@bib39]

CCL28, a chemokine with a chemoattractant activity for lymphocytes, is upregulated in *H pylori* infection--related human gastritis, and is of 6 genes that are reported to be significantly correlated with the aggressiveness of gastric cancer.[@bib32], [@bib40], [@bib41], [@bib42], [@bib43] We observed CCL28-positive cells in the stomach of *stCldn18--/--* mice from middle age (\>40 w.o.) ([Figure 4](#fig4){ref-type="fig"}*D*). The expression level of CCL28 was also increased in the stomach of *stCldn18--/--* mice, especially at old age (\>60 w.o.) ([Figure 4](#fig4){ref-type="fig"}*D*). To further examine CCL28's contribution to the *stCldn18--/--* mouse gastritis, POL7085, an inhibitor of the CCL28-CCR10 cascade,[@bib44], [@bib45] was administered to the *stCldn18--/--* mice. After 1 week of POL7085 administration, the expression levels of inflammation-related genes such as CXCL5, NF-kB, and IKKβ were dramatically decreased in the middle-aged *stCldn18--/--* mice (around 50 w.o.) ([Figure 4](#fig4){ref-type="fig"}*E*). Thus, CCL28 may be a key cytokine for inducing chronic active gastritis in the *stCldn18--/--* mice.

Collectively, our results showed that CCL28 may be involved in the transition from active gastritis to chronic active gastritis in the *stCldn18--/--* mice. In addition, the upregulation of other inflammatory signals such as CXCL5, STAT3, and IKKβ/NF-κB could be indicative of tumor-directed changes, such as EMT, hyperproliferation, antiapoptosis, and angiogenesis, in the *stCldn18--/--* mice.

Induction of Spasmolytic Polypeptide--Expressing Metaplasia in Young and Aged *stCldn18--/--* Mice {#sec1.5}
--------------------------------------------------------------------------------------------------

Recently, spasmolytic polypeptide--expressing metaplasia (SPEM) was suggested to be the origin of cancer stem cells.[@bib6] We previously reported that young *stCldn18--/--* mice exhibit SPEM, which was probably caused by the acute decrease in the number of parietal cells due to gastric acid leakage.[@bib14] In the present study, we found that aged *stCldn18--/--* mice (around 50 w.o.) also showed SPEM, which was double-positive for TFF2 and Pepsin C, near the bottom of the gastric glands ([Figure 5](#fig5){ref-type="fig"}*A*). Ki-67 staining showed that the TFF2 and Pepsin C double-positive SPEM cells were proliferative ([Figure 5](#fig5){ref-type="fig"}*A*).Figure 5**Induction of spasmolytic polypeptide--expressing metaplasia (SPEM) in young and aged *stCldn18--/--* mice.** (*A*) Immunofluorescence micrographs for TFF2 (*green*) and Pepsin C (*blue*) as SPEM cell markers co-stained with Ki-67 (*red*) and DAPI (*white*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. SPEM cells were clearly observed in the stomach of the *stCldn18--/--* mice. The Ki-67 signals partially coincided with the SPEM cells (*arrows*). Representative images from at least 2 independent experiments are shown. Scale bars = 100 μm. (*B*) Expression levels of the tumor-related alternatively spliced variants of CD44, and GAPDH in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.) quantified by conventional RT-PCR. (*C*) Immunofluorescence micrographs for TFF2 (*green*) and Pepsin C (*blue*) as SPEM cell markers co-stained with CD44 (*red*) and DAPI (*white*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. CD44-positive cells were clearly observed in the stomach of the *stCldn18--/--* mice. The CD44 signals partially coincided with the SPEM cells (*arrows*). Representative images from at least 3 independent experiments are shown. Scale bars = 100 μm.

Upregulation of CD44 Splicing Variants in Middle-Aged *stCldn18--/--* Mice {#sec1.6}
--------------------------------------------------------------------------

SPEM cells are known to express splicing variants of CD44, which are often found at high expression levels in cancer stem cells.[@bib46], [@bib47], [@bib48], [@bib49] In this respect, conventional real-time polymerase chain reaction (RT-PCR) showed that the CD44 v8-v10 variants were highly expressed in the stomach of *stCldn18--/--* mice from middle age (\>40 w.o.) ([Figure 5](#fig5){ref-type="fig"}*B*), and CD44-positive SPEM cells were observed in the stomach of aged *stCldn18--/--* mice ([Figure 5](#fig5){ref-type="fig"}*C*). These results suggested that the tumor-directed stemness of the SPEM cells increased in the *stCldn18--/--* mice. Supporting this hypothesis, the expression level of TLR2, an innate immune receptor with a role in maintaining stemness,[@bib50] increased in the *stCldn18--/--* mice with age ([Figure 6](#fig6){ref-type="fig"}*A*). We also found CD44 and TLR2 double-positive cells in the stomach of *stCldn18--/--* mice ([Figure 6](#fig6){ref-type="fig"}*B*). In addition, the expression levels of other stemness markers such as SOX2, c-Myc, Ascl2, and matrix metalloproteinase-7 (MMP7) were increased in the stomach of the aged *stCldn18--/--* mice ([Figure 6](#fig6){ref-type="fig"}*C*).[@bib51] The expression level of MMP7 was especially increased in the stomach of *stCldn18--/--* mice at 100 w.o., which is notable because MMP7 is known to be involved in cell invasion and in the stemness of cancer stem cells.[@bib51]Figure 6**Upregulation of TLR2 in aged *stCldn18--/--* mice.** (A) (*Left*) Immunofluorescence micrographs for TLR2 (*green*) co-stained with α-catenin (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). High-magnification images are shown in insets. TLR2-positive cells were clearly observed in the stomach of *stCldn18--/--* mice after middle age (40, 60, and 100 w.o.). At middle age (40 w.o.), the TLR2-positive cells did not show the characteristics of gastric epithelium (*arrowheads*), but at old age (60, and 100 w.o.), the TLR2-positive cells might have been gastric epithelial cells (*arrows*). Representative images from at least 2 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 50 μm. (*Right*) Expression level of TLR2 in the stomach from *stCldn18+/+* (n = 4, 4, 10, 10) and *stCldn18--/--* mice (n = 8, 4, 12, 16) (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \*\**P \<* .01. (*B*) Immunofluorescence micrographs for CD44 (*green*), co-stained with TLR2 (*red*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (100 w.o.). High-magnification images are shown in insets. CD44-and TLR2-double-positive cells were clearly observed in the stomach of the *stCldn18--/--* mice (*arrows*). Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 50 μm, high magnification: 50 μm. (C) Expression levels of c-Myc, hypoxia-inducible factor HIF2a, MMP7, SOX2, and ASCL2 in the stomach from *stCldn18+/+* (n = 5, 4, 12, 9) and *stCldn18--/--* (n = 9, 4, 13, 16) mice (8, 40, 60, and 100 w.o.) quantified by qRT-PCR. The expression level of MMP7 was especially increased in the stomach of the 100 w.o. *stCldn18--/--* mice. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\*\**P \<* .001.

Development of Intestinal Metaplasia and Ectopic Gastric Glands in Aged *stCldn18--/--* Mice {#sec1.7}
--------------------------------------------------------------------------------------------

Gastric intestinal metaplasia is known to be a precancerous change in which the gastric mucosa is replaced by intestinal epithelium.[@bib52] In this respect, the expression levels of *Cldn2*, *Cldn4*, and *Cldn7* were significantly increased in the stomach of *stCldn18--/--* mice ([Figure 7](#fig7){ref-type="fig"}*A*), and these *Cldns* are known to be highly expressed in intestinal epithelial cells.[@bib53] Consistent with this finding, *Cldn2*- or *Cldn7*-positive cells were clearly observed in the stomach of *stCldn18--/--* mice ([Figure 7](#fig7){ref-type="fig"}*B*). Furthermore, villin, a marker for intestinal epithelial cells, was detected in the stomach of *stCldn18--/--* mice ([Figure 7](#fig7){ref-type="fig"}*B*). These results suggested that gastric intestinal metaplasia developed in the *stCldn18--/--* mice. Importantly, the changes in the expression levels of these *Cldns* could also be associated with the gastric pathologies of the *stCldn18--/--* mice.Figure 7**Development of intestinal metaplasia and ectopic gastric gland in aged *stCldn18--/--* mice.** (*A*) Expression levels of *Cldns* in the stomach from s*tCldn18+/+* (n = 6), and *stCldn18--/--* (n = 7), mice at 100 w.o. quantified by qRT-PCR. The expression levels of *Cldn2*, *4*, *7*, and *luCldn18* were significantly increased in the stomach of *stCldn18--/--* mice at old age. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. n.s., not significant. \**P \<* .05. (*B*) Immunofluorescence micrographs for Cldn2 or Cldn7 (*green*) co-stained with E-cadherin (*red*) and with or without villin (*blue*) in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (around 50 w.o.). Representative images from at least 3 independent experiments are shown. Scale bars = 100 μm. (*C*) Hematoxylin and eosin--stained images of the ectopic gastric gland in aged *stCldn18--/--* mice. Ectopic gastric glands were found in 1 of 3 old *stCldn18--/--* mice by examining stomach tissue slices. Right panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50, 10 μm, left to right panel. (*D*) (*Left*) Immunofluorescence micrographs for TFF2 (*green*) and Pepsin C (*blue*) as SPEM cell markers co-stained with CD44 (red) and DAPI (*white*) in the ectopic gastric gland from *stCldn18--/--* mice (around 50 w.o.). (Right) Representative immunofluorescence micrographs for TFF2 (*green*), and Pepsin C (*blue*) as SPEM cell markers co-stained with Ki-67 (*red*) and DAPI (*white*) in the ectopic gastric gland from *stCldn18--/--* mice (around 50 w.o.). *Right* panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50 μm, left to right panel. (*E*) (*Left*) Immunofluorescence micrographs for *Cldn2* (*green*) co-stained for E-cadherin (*red*) and villin (*blue*) in the ectopic gastric gland from *stCldn18--/--* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50 μm, left to right panel. (*Middle, Right*) Immunofluorescence micrographs for *Cldn4* or *Cldn7* (*green*) co-stained for E-cadherin (*red*) in the ectopic gastric gland from *stCldn18--/--* mice (around 50 w.o.). Right panels are magnified images of the boxed regions in the left panels. Representative images from at least 2 independent experiments are shown. Scale bars = 100, 50 μm, left to right panel.

In the old *stCldn18--/--* mice (100 w.o.), ectopic gastric glands formed outside the gastric mucosa ([Figure 7](#fig7){ref-type="fig"}*C*). This ectopic gastric gland was histologically similar to the "gastritis cystica profunda" or to the "invasive submucosal gland," which are observed in *H pylori*--related gastritis,[@bib54] and it was recently reported that the "invasive submucosal gland" represents the stage between intestinal metaplasia and gastric cancer in a study in Mongolian gerbils.[@bib55] Although the ectopic gastric gland we observed had features of intestinal epithelium, which is villin-, *Cldn2*-, *Cldn4*-, or *Cldn7*-positive ([Figure 7](#fig7){ref-type="fig"}*E*), in addition to being CD44- or Ki-67--positive ([Figure 7](#fig7){ref-type="fig"}*D*), it did not show any obvious dysplastic changes such as nuclear atypia.

Activation of *Wnt* Signaling in Aged *stCldn18--/--* Mice {#sec1.8}
----------------------------------------------------------

*Wnt* signaling is known to be activated in 30%--50% of human gastric cancers.[@bib56] Considering that CXCL5, CD44, and MMP7, which were upregulated in the aged *stCldn18--/--* mouse stomach, are related to be *Wnt* signaling,[@bib57], [@bib58], [@bib59] *Wnt* signaling might be involved in the *stCldn18--/--* mouse gastric tumorigenesis. In this respect, the nuclear localization of β-catenin, a marker for *Wnt* signaling activation,[@bib60] was observed in the stomach of *stCldn18--/--* mice from middle age (\>40 w.o.) ([Figure 8](#fig8){ref-type="fig"}*A*). Furthermore, the expression level of *Wnt1a* was especially increased in the stomachs with gastric tumors of 100-w.o. *stCldn18--/--* mice ([Figure 8](#fig8){ref-type="fig"}*B*). The expression levels of *Wnt4* and *Wnt5* gradually increased in the stomach of *stCldn18--/--* mice with age ([Figure 8](#fig8){ref-type="fig"}*C*). These results showed that Wnt signaling was increasingly activated in the stomach of *stCldn18--/--* mice with age. Thus, the activation of *Wnt* signaling could be related to the gastric tumorigenesis in *stCldn18--/--* mice.Figure 8**Activation of *Wnt* signaling in aged *stCldn18--/--* mice.** (*A*) Immunohistological micrographs for β-catenin as an EMT marker in the stomach from *stCldn18+/+* and *stCldn18--/--* mice (8, 40, 60, and 100 w.o.). A nuclear localization of β-catenin, indicative of *Wnt* signaling activation, was observed in the stomach of *stCldn18*--/-- mice after middle age (40, 60, and 100 w.o.) (*arrows*). Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm. (*B*) Expression level of *Wnt1a* in the stomach from stCldn18+/+ mice (n = 11, 10), and stCldn18--/-- mice with hyperplasia (n = 8, 13), with gastric tumor (n = 5, 3) (60, and 100 w.o.) quantified by qRT-PCR. *Wnt1a* was especially increased in the gastric tumors of the 100-w.o. *stCldn18--/--* mice. Gene expressions were normalized to GAPDH. (*C*) Expression level of *Wnt2*, *Wnt3*, *Wnt4*, and *Wnt5* in the stomach from *stCldn18+/+* (n = 5, 4, 12, 9) and *stCldn18--/--* (n = 9, 4, 13, 16) mice (10, 40, 60, and 100 w.o.), quantified by qRT-PCR. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. \**P \<* .05; \*\*\**P \<* .001.

Acceleration of Gastric Tumorigenesis Under Chronic Active Gastritis in *Wnt1-*Overexpressing Transgenic *stCldn18--/--* Double-Mutant Mice {#sec1.9}
-------------------------------------------------------------------------------------------------------------------------------------------

As previously reported, *Wnt1*-overexpressing transgenic (*Wnt1-*Tg) mice developed small gastric polyps without severe gastritis.[@bib61] To examine the relationship between *stCldn18*-deficiency--induced chronic gastritis and *Wnt*-dependent gastric tumorigenesis, we crossed *Wnt1-*Tg with *stCldn18--/--* mice to obtain double-mutant (DM) mice. The *Wnt*1-Tg and DM mice were born, and grew with a macroscopically normal appearance, similar to the *stCldn18--/--* mice.

At a young age (8 w.o.), the *Wnt*1-Tg mice showed no severe gastric pathologies, in contrast to the *stCldn18--/--* and DM mice ([Figure 9](#fig9){ref-type="fig"}*A*--*C*). The DM mouse stomach also showed increased expression levels of inflammatory cytokines such as IL-1β, TNF-α, CXCL1, and CCL28, similar to the *stCldn18--/--* mouse stomach ([Figure 9](#fig9){ref-type="fig"}*B*). A few CD3^+^ T lymphocytes were observed in the DM mouse stomach ([Figure 9](#fig9){ref-type="fig"}*C*). These results indicated that at the young age (8 w.o.), the DM mice developed gastritis similarly to the *stCldn18--/--* mice.Figure 9**No tumor formation in young *Wnt1*-Tg *stCldn18--/--* DM mice.** (*A*) Hematoxylin and eosin--stained images of the stomach from *stCldn18+/+*, *Wnt*1-Tg, *stCldn18--/--*, and *Wnt1*-Tg mice crossed with *stCldn18--/--* DM mice at a young age (8 w.o.). No obvious difference was detected in the stomachs between *stCldn18--/--* and DM mice at the young age. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm. (*B*) Expression levels of IL-1β, TNF-α, CXCL1, CCL28, and CXCL5 in the stomach from s*tCldn18+/+*, *Wnt1*-Tg, *stCldn18--/--*, and DM mice at a young age (8 w.o.) quantified by qRT-PCR (n = 8, 4, 10, 11). No significant differences were detected between the stomachs of *stCldn18--/--* and DM mice at the young age. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons among more than 3 groups were performed using the Kruskal-Wallis 1-way analysis of variance on ranks (*P \<* .01) followed by the Steel-Dwass test. \**P \<* .05. (*C*) Immunofluorescence micrographs for CD3 or CXCL5 (*green*) co-stained with ZO-2 (*red*) and DAPI (*blue*) in the stomach from s*tCldn18+/+*, *Wnt1*-Tg, *stCldn18--/--*, and DM mice at a young age (8 w.o.). High-magnification images are shown in insets. No significant differences were detected between the stomachs of *stCldn18--/--* and DM mice at the young age. Representative images from at least 3 independent experiments are shown. Scale bars = low magnification: 100μm, high magnification: 10 μm.

At middle age (40 w.o.), all of the DM mice developed gastric tumors, while none of the *stCldn18--/--* mice did ([Figure 10](#fig10){ref-type="fig"}*A*). Hematoxylin and eosin--stained images of the DM mouse stomach showed that the density of the gastric glands was increased in a back-to-back manner ([Figure 10](#fig10){ref-type="fig"}*B*), suggesting that dysplastic changes were induced. Inflammatory cytokines such as IL-1β, TNF-α, CXCL1, CCL28, and CXCL5 were upregulated in both the *stCldn18--/--* and DM mouse stomachs ([Figure 10](#fig10){ref-type="fig"}*C*). The number of CD3^+^ T lymphocytes was also increased in the *stCldn18--/--* and the DM mouse stomach compared with the *stCldn18+/+* mouse and *Wnt1*-Tg mouse stomach ([Figure 10](#fig10){ref-type="fig"}*D*). At this age, the *Wnt1-*Tg mice did not show severe gastritis/gastric tumor formation but small foveolar hyperplasia, the phenotype of which was reported previously ([Figure 10](#fig10){ref-type="fig"}*A--D*).[@bib61]Figure 10**Accelerated gastric tumorigenesis under chronic active gastritis in aged *Wnt1*-Tg *stCldn18--/--* DM mice.** (*A*) Macroscopic images of the stomach from *stCldn18+/+*, *Wnt1*-Tg, *stCldn18--/--*, and DM mice at middle age (40 w.o.). Gastric tumors were observed in all of the stomachs of DM mice but not of *stCldn18--/--* mice at middle age (40 w.o.). Representative images from at least 3 independent experiments are shown. Scale bars = 1 cm. (*B*) Hematoxylin and eosin--stained images of the stomach from *stCldn18+/+*, *Wnt1*-Tg, *stCldn18--/--*, and DM mice at middle age (40 w.o.). Dysplastic changes were observed in the stomach of DM mice at middle age (40 w.o.). Representative images from at least 2 independent experiments are shown. Scale bars = low magnification = 1 mm, high magnification = 50 μm. (*C*) Expression levels of IL-1β, TNF-α, CXCL1, CCL28, and CXCL5 in the stomach from s*tCldn18+/+*, *Wnt1*-Tg, *stCldn18--/--*, and DM mice at middle age (40 w.o.) quantified by qRT-PCR (n = 4, 4, 4, 5). The expression levels of IL-1β, CCL28, and CXCL5 were increased in the stomach of *stCldn18--/--* and DM mice compared with those of *stCldn18+/+* and *Wnt1*-Tg mice at middle age. Gene expressions were normalized to GAPDH. Results are expressed as mean ± SD. Comparisons among more than 3 groups were performed using the Kruskal-Wallis 1-way ANOVA on ranks (*P \<* .01) followed by the Steel-Dwass test. no symbol, not significant. (*D*) Immunofluorescence micrographs for CD3 or CXCL5 (*green*) co-stained with ZO-2 (*red*) and DAPI (*blue*) in the stomach from *stCldn18+/+*, *Wnt1*-Tg, *stCldn18--/--*, and DM mice at middle age (40 w.o.). The levels of CD3- and CXCL5-positive cells (*arrows*) were increased in the stomach of *stCldn18--/--* and DM mice at middle age (40 w.o.). High-magnification images are shown in insets. Representative images from at least 3 independent experiments are shown. Scale bars = 50 μm, 10 μm.

Collectively, the extent of gastritis in the DM mice was similar to that in the *stCldn18--/--* mice, except for the level of CXCL5, which is a target of *Wnt* signaling. ([Figure 10](#fig10){ref-type="fig"}*A--D*). These findings suggested that the *Wnt*-dependent gastric tumorigenesis might be accelerated under the severe gastritis induced by the *stCldn18* deficiency.

Similarity of Gastric Tumorigenesis in *stCldn18--/--* Mice to *H pylori* Infection--Related Tumorigenesis in Humans {#sec1.10}
--------------------------------------------------------------------------------------------------------------------

To compare the mouse model and human disease, we analyzed the expression levels of *Cldn18* in human gastritis samples and in various human gastric tumors. Gastric hyperplastic polyp (HP), which is usually associated with *H pylori* infection in humans, develops in the context of chronic inflammation.[@bib62] Fundic gland polyp (FGP), a major human tumor, is a hyperplasia that is not associated with either inflammation or *H pylori* infection, and is considered to be different from the inflammation-related process such as that seen in the *stCldn18--/--* mice.[@bib63] Another disease, Peutz-Jeghers polyp (PJP), is an autosomal-dominant inherited disorder characterized by hamartoma in the digestive tract, including gastric tumors, and also has a different disease process from that seen in the *stCldn18--/--* mice.[@bib64]

Pathologically, the tumor regions in the *stCldn18--/--* mice closely resembled human HP ([Figure 11](#fig11){ref-type="fig"}*A*). The expression level of *Cldn18* in HP was clearly lower than that in FGP or PJP ([Figure 11](#fig11){ref-type="fig"}*B*), and the expression level of CXCL5 in HP was clearly higher than that in FGP or PJP ([Figure 11](#fig11){ref-type="fig"}C). These results suggested that the expression level of *Cldn18* was inversely correlated with that of CXCL5 in HP. These data suggested that the *stCldn18--/--* mouse gastric tumors at least partly resembled human HP.Figure 11**Inverse correlation between the expression levels of *Cldn18* and CXCL5 in human HP and cancer.** (*A*) Hematoxylin and eosin--stained images of human HP, FGP, and PJP. These gastric tumors are the result of *H pylori* infection, a side effect of proton pump inhibitor therapy, and an inherited gastric tumor of hamartoma/hyperplasia, respectively. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively. (*B*) (*Left*) Immunohistological micrographs for *Cldn18* in human HP, FGP, and PJP. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively. (*Right*) In the graphs, 4+: 75%--100%, 3+: 50%--75%, 2+: 25%--50%, 1+: 1%--25%, 0: 0% of the epithelial cells were stained. The number of Cldn18-positive gastric epithelial cells was significantly decreased in human HP compared with FGP and PJP. (*C*) (*Left*) Immunohistological micrographs for CXCL5 in human HP, FGP, and PJP. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 3 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively. (*Right*) In the graphs, 4+: 75%--100%, 3+: 50%--75%, 2+: 25%--50%, 1+: 1%--25%, 0: 0% of the epithelial cells were stained. The number of CXCL5-positive gastric epithelial cells (*arrows*) was significantly increased in human HP compared with FGP and PJP. (*D*) (*Left*) Hematoxylin and eosin--stained images of a human gastric adenoma. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 2 independent experiments are shown. Scale bars = 1 mm and 200μm in the upper and lower panels, respectively. (*Middle, Right*) Immunohistological micrographs for claudin-18 and CXCL5 in the human gastric adenoma. Lower panels are magnified images of the boxed regions in the upper panels. Representative images from at least 2 independent experiments are shown. Scale bars = 1 mm and 200 μm in the upper and lower panels, respectively.

Furthermore, we noted that the *Cldn18* expression level in a gastric adenocarcinoma that originated from HP was reduced ([Figure 11](#fig11){ref-type="fig"}*D*). The CXCL5 expression were also upregulated in the adenocarcinoma region of the human stomach ([Figure 11](#fig11){ref-type="fig"}*D*).

Toxic Effects of Gastric Acid in Aged *stCldn18--/--* Mice {#sec1.11}
----------------------------------------------------------

In the *stCldn18--/--* mice, the long-term gastritis continued without healing. In this respect, only a few parietal cells remained in the aged *stCldn18--/--* mice, suggesting that gastric acid secreted by these cells promoted the gastritis. After 1 week of administering the H~2~-blocker cimetidine, an inhibitor of gastric acid secretion, to middle-aged *stCldn18--/--* mice (around 50 w.o.), the expression levels of inflammation-related genes such as CXCL5, IKKβ, and NF-kB were dramatically decreased ([Figure 4](#fig4){ref-type="fig"}*E*). This result suggested that the remaining parietal cells could still secrete gastric acid to promote gastritis.

Importantly, it was still unclear to what extent the gastric acid leakage due to the *stCldn18* deficiency directly contributed to the gastritis and gastric tumorigenesis. Our present findings suggested that the activation of several signaling pathways, including the cytokine-, stemness-, and Wnt-signaling pathways, might contribute to these gastric pathologies under the severe gastritis induced by the *stCldn18* deficiency. For example, the administration of cimetidine or POL7085 dramatically inhibited the gastritis, and also decreased the expression level of Ascl2, a stemness marker, in middle-aged *stCldn18--/--* mice (around 50 w.o.) ([Figure 4](#fig4){ref-type="fig"}*E*). Thus, it was possible that the stemness was also increased under the chronic gastritis induced by the *stCldn18* deficiency.

Process of Gastric Tumorigenesis in Young to Aged *stCldn18--/--* Mice Without *H pylori* Infection {#sec1.12}
---------------------------------------------------------------------------------------------------

Based on our findings, we propose a scheme in which the loss of *stCldn18* creates a microenvironment that leads to chronic active gastritis and gastric tumor formation in the absence of *H pylori* infection ([Figure 12](#fig12){ref-type="fig"}). The active gastritis, which occurred in young *stCldn18--/--* mice (\<8 w.o.), transitioned to chronic active gastritis with expression of the chemoattractant CCL28 in middle-aged *stCldn18--/--* mice (40 w.o.). In the old *stCldn18--/--* mice (\>60 w.o.), gastric tumors formed with the expression of CXCL5, which promoted EMT downstream of *Wnt*. In this tumorigenesis process, SPEM cells appeared. Changes in cell characteristics were suggested by the upregulation of CD44, TLR2, and *Wnt*. Furthermore, the gastric tumorigenesis was accelerated in *Wnt1*-Tg *stCldn18--/--* DM mice.Figure 12**Schematic illustration of the signaling pathways in *stCldn18--/--* mouse gastric tumorigenesis.** Scheme of the signaling pathways in *stCldn18--/--* mouse gastric tumorigenesis. In the gastric tumorigenesis of *stCldn18--/--* mice, several signaling pathways, including the cytokine-, stemness-, and Wnt- signaling pathways, may be activated to accelerate gastric tumorigenesis under the *stCldn18* deficiency*--*induced chronic active gastritis.

Our analysis provides evidence that long-term *stCldn18* deficiency induces chronic active gastritis and then gastric tumors in mice even in the absence of *H pylori* infection. Several signaling pathways, including the cytokine-, stemness-, and Wnt-signaling pathways, may be activated to accelerate the gastric tumorigenesis under the *stCldn18* deficiency--induced chronic active gastritis. Notably, the process of *stCldn18*--/-- mouse gastric tumorigenesis partially resembled that of *H pylori* infection--related human carcinogenesis.

Discussion {#sec2}
==========

Disruption of the paracellular barrier function of TJs is thought to be an important factor in the progression of gastritis and gastric cancer,[@bib14] although its contribution to gastric pathologies has not been thoroughly analyzed. In this respect, we previously reported that in young *stCldn18--/--* mice, acute oxyntic atrophic gastritis is induced by the leakage of gastric acid from the gastric lumen to the submucosal space through *stCldn18--/--* TJs. In the present study, we analyzed the *stCldn18--/--* mice over their entire lifetime. Our analysis provides evidence that long-term *stCldn18* deficiency induces gastric tumors to form under chronic active gastritis in mice without *H pylori* infection, in a process involving several signaling pathways, including the cytokine-, stemness-, and Wnt-signaling--activated pathways.

CCL28 could be a key chemokine causing the *stCldn18--/--* mouse gastritis to become chronic, based on the following findings. The expression of CCL28 is reported to be induced by hypoxia-inducible factors under hypoxic conditions,[@bib42] suggesting that hyperproliferative tumor-related hypoxia could upregulate CCL28 expression in the *stCldn18--/--* mice ([Figure 6C](#fig6){ref-type="fig"}). It is also reported that the expression of CD44 v8-v10 variants is induced by hypoxia to promote cell proliferation.[@bib65] Thus, a positive feedback loop involving CD44 upregulation, cell proliferation, and hypoxia could increase the CCL28 expression to accelerate the transition from active to chronic active gastritis in the *stCldn18--/--* mice.

Recently, SPEM cells were suggested to be the origin of cancer stem cells.[@bib66] Evidence also suggests that prolonged gastritis eventually changes the stemness of SPEM cells.[@bib67] In the *stCldn18--/--* mice, the expression levels of stemness markers were increased from middle age, when chronic active gastritis was induced. Therefore, we speculate that the *stCldn18* deficiency--induced chronic active gastritis promoted tumor-directed changes in the SPEM cells.

The EMT upregulates cell migration and invasion in cancer development.[@bib68] In this respect, we observed that CXCL5, a downstream target of *Wnt* signaling and an EMT-inducible cytokine, was increased during the *stCldn18--/--* mouse gastric tumorigenesis. Although invasive gastric cancer did not form in the s*tCldn18--/--* mice, EMT presumably caused some morphological changes in the gastric glands to accelerate the tumorigenesis.

The expression of CXCL5, a target of *Wnt* signaling, was dramatically increased in the DM mice at middle age (40 w.o.). However, the CXCL5 expression was not increased in DM mice at a young age (8 w.o.), when severe gastritis was not observed. These findings suggested that the chronic active gastritis induced by *stCldn18* deficiency dramatically potentiated the effect of *Wnt* signaling. Consistent with this possibility, the CXCL5 expression was upregulated in *stCldn18--/--* mice especially at old age. Thus, changes in the characteristics of the *stCldn18*-deficiency--induced gastritis might be required for the activation of *Wnt* signaling to accelerate the gastric tumorigenesis. As *Wnt* signaling is reported to be coordinated with Notch to regulate gastric stem cell proliferation and differentiation, it is possible that the upregulation of Notch is also involved in the *stCldn18--/--* mouse gastric tumorigenesis.[@bib69]

Fox's group recently reported that gastric pathologies including gastritis and gastric tumors were observed in their *Cldn18--/--* mice, similar to our *stCldn18--/--* mice.[@bib27] They globally analyzed the signaling pathways by RNA sequencing, and, like us, found that *Wnt* signaling was involved in the *Cldn18--/--* mouse gastric tumorigenesis.[@bib27] In our study, we further used DM mice to examine the tumorigenic roles of *Wnt* signaling under the chronic gastritis induced by *stCldn18* deficiency.

It was recently reported that in lung-type *Cldn18* gene knockout (*luCldn18--/--*) mice, *luCldn18* loss induced the nuclear localization of YAP, which promoted the development of lung adenocarcinoma.[@bib70] Although the *luCldn18* expression that was upregulated in the stomach of our *stCldn18--/--* mice, [@bib14] the nuclear localization of YAP could might be related to the gastric tumorigenesis in our *stCldn18--/--* mice.

Collectively, we found that the *stCldn18* deficiency induced the development of gastric tumors under chronic active gastritis in the absence of *H pylori* infection. Age-dependent changes in several signaling networks involving inflammation-, stemness-, and *Wnt*-related pathways, may accelerate this gastric tumorigenesis in a multi-faceted manner.

Materials and Methods {#sec3}
=====================

Ethics Statement {#sec3.1}
----------------

Animal experiments were performed in accordance with protocols approved by the Animal Studies Committee of Osaka University School of Medicine. Recombinant DNA experiments were carried out in accordance with protocols approved by Osaka University. Studies using human samples were performed at Hiroshima University in accordance with protocols approved by the Hiroshima University School of Medicine Ethics Committee.

Antibodies {#sec3.2}
----------

Antibodies used for immunochemical staining and fluorescence-activated cell sorting (FACS) analyses are listed in [Table 1](#tbl1){ref-type="table"}.Table 1Antibodies Used in Immunofluorescence Images and FACS AnalysisEpitopeSupplierCatalog numberConjugateKi-67Santa Cruz Biotechnologysc-7846UnconjugateH,K-ATPaseMBLD031-3UnconjugateGr-1BD Pharmingen553123UnconjugateCD3BD Pharmingen555273UnconjugateCXCL5Bioss Antibodiesbs-2549RUnconjugateCXCL5Cell Signaling TechnologyMAB433UnconjugateCCL28BioLegend525802UnconjugateTFF2Bioss Antibodiesbs-1921RUnconjugatePepsin CSanta Cruz Biotechnologysc-51188UnconjugateCD44BioLegend103001UnconjugateTLR2BioLegend121802UnconjugateE-cadherinDr. Masatoshi TakeichiECCD-2Unconjugateα-cateninSigmaC-2081UnconjugateZO-2Santa Cruz Biotechnologysc-8148UnconjugateClaudin-2Immuno-Biological Laboratories18825UnconjugateClaudin-4Invitrogen364800UnconjugateClaudin-7Invitrogen349100UnconjugateClaudin-18LifeSpan BioSciencesLS-C146633UnconjugateVillinSanta Cruz Biotechnologysc-7672UnconjugateActive β-cateninCell Signaling Technology88145UnconjugateCD4BioLegend100515APCCD8aBioLegend100723Alexa488CD11bBioLegend101217Alexa488Ly-6GBioLegend127613APC

Generation of *stCldn18--/--, Wnt1-*Tg, and *Wnt1-*Tg *stCldn18--/--* DM Mice {#sec3.3}
-----------------------------------------------------------------------------

The method for generating *stCldn18-*deficient (*stCldn18--/--*) mice was previously reported.[@bib14] In brief, the first exon of the mouse *stCldn18* locus was replaced with a neomycin-resistance gene by a conventional homologous recombination technique. The obtained heterogeneous, A129 R1 ES cells were injected into ICR blastocysts, and transplanted into the ovaries of foster mother mice. The high-percentage male chimeras were bred with female C57BL/6J mice, and the resulting heterogeneous mice were intercrossed to generate *stCldn18--/--* mice.

The method for generating *Wnt1-*Tg mice was previously reported.[@bib61] Briefly, *Wnt1* complementary DNA was excised and cloned into pBluescript (Stratagene, La Jolla, CA) to construct a pK19-*Wnt1* transgenic vector. The transgenic vector was microinjected into fertilized eggs of F1 (C3H and C57BL/6) hybrid females, which were crossed with C57BL/6 males to generate *Wnt1-*Tg mice. *Wnt1* transgene expression driven under keratin 19 (K19) promotor is transcriptionally active in the gastric epithelium.[@bib61]

*stCldn18--/--* and *Wnt1-*Tg mice were intercrossed to generate *Wnt1*-Tg *stCldn18--/--* DM mice.

Mice were bred in specific pathogen-free conditions, and were negative for *H pylori*.

Histological Staining {#sec3.4}
---------------------

For the immunohistological staining of paraffin sections, a freshly excised mouse stomach was fixed with 10% neutral buffered formalin solution at 4°C for 24 hours. After fixation, the stomach was dehydrated in a graded ethanol series and embedded in paraffin using a Spin Tissue Processor (Thermo Scientific, Tokyo, Japan). The samples in paraffin were cut into 5-μm-thick sections, deparaffinized twice by immersion in xylene at room temperature for 3 minutes, and hydrated by being passed through a series of decreasing ethanol concentrations (100%, 95%, 90%, 80%, 70%, and 50%) at room temperature for 1 minute each. The samples were then blocked with phosphate-buffered saline (PBS) containing 1% bovine serum albumin at room temperature for 10 minutes, and stained with primary antibodies at 4°C overnight. After 3 washes with PBS, the samples were stained with Horseradish peroxidase (HRP)-labeled secondary antibodies for 1 hour at room temperature. After 3 washes with PBS, the samples were developed with 3,3'-Diaminobenzidine tetrahydrochloride (DAB) at room temperature for 10 minutes. The samples were then rinsed with running tap water for 5 minutes. After counterstaining with hematoxylin, the samples were dehydrated, and mounted with Marinol (Muto Pure Chemicals Co, Ltd, Tokyo, Japan; Cat. No. 20091).

For the immunofluorescence staining of frozen sections, the mouse stomach was washed with ice-cold PBS, embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek Japan Co, Ltd, Tokyo, Japan; Cat. No. 4583), and was frozen in liquid N~2~. The frozen samples were cut into 5-μm-thick sections, and air dried at room temperature for 20 minutes. The sections were fixed with methanol at --20°C for 10 minutes, or with PBS containing 2% paraformaldehyde at room temperature for 10 minutes after permeabilization with PBS containing 0.1% Triton-X100 at room temperature for 10 minutes. The samples were then blocked with PBS containing 1% bovine serum albumin at room temperature for 10 minutes. After blocking, the samples were stained with primary antibody overnight at 4°C. After 3 washes with PBS, the samples were stained with fluorescently labeled secondary antibodies and with 1 mg/mL 4′,6-diamidino-2-phenylindole (DAPI) for 1 hour at room temperature. After 3 washes with PBS and 1 with deionized distilled water, the samples were embedded in fluorescence mounting medium (Dako Japan, Tokyo, Japan; Cat. No. S3023).

For the immunofluorescent staining of paraffin sections, deparaffinized and hydrated 5-μm-thick sections were prepared as described above. The samples then underwent antigen retrieval in deionized distilled water containing 0.5% Immunosaver (Nissin EM, Tokyo, Japan) at 98°C for 45 minutes. After antigen retrieval, the samples were washed 3 times with PBS. The samples were then blocked, and stained with appropriate antibodies as described above.

Microscopy {#sec3.5}
----------

Immunofluorescent images were captured or tiled by an LSM710 confocal laser-scanning microscope (Carl Zeiss Japan, Tokyo, Japan) equipped with a 405-nm blue diode laser, 488-nm argon laser, 561-nm DPSS laser, and 633-nm HeNe laser, and with a Plan-Apochromat 20×/0.8 M27 objective, C-Apochromat 40×/1.2 W Corr M27 objective, and C-Apochromat 63×/1.20 W Corr M27 objective. The acquired images were analyzed by ZEN 2012 (Carl Zeiss Japan).

Bright field images were captured or tiled by a BZ-X700 all-in-1 microscope (Keyence Japan, Osaka, Japan) equipped with CFI Plan Apo λ4x, CFI Plan Apo λ10x, CFI Plan Apo λ20x, and CFI Plan Apo λ40x objectives. The acquired images were analyzed by a BZ-X Analyzer (Keyence Japan).

Flow Cytometry {#sec3.6}
--------------

A glandular portion of a freshly excised mouse stomach was washed with cold PBS, and minced with scissors. The minced tissue was washed twice with cold PBS and centrifuged at 600 *g* at 4°C for 5 minutes, then incubated in 20 mL of Hank's balanced salt solution (HBSS) containing 10% fetal bovine serum (FBS), 50-mM EDTA, and 15-mg/mL dithiothreitol at 37°C for 10 minutes. After centrifugation at 600 *g* at room temperature for 10 minutes, the tissue was resuspended and incubated in HBSS containing 300 U/mL collagenase type 1 (Worthington Biochemical Corporation, Lakewood, NJ; Cat. No. LS004196), 0.01/mg/mL DNase 1 (Roche Diagnostics, Tokyo, Japan; Cat. No. 10104159001), and 10% FBS at 37°C for 50 minutes with intermittent pipetting. The recovered cells were sequentially filtered using a 100-, 40-, and 10-μm-pore-sized nylon mesh. After filtration, the single-cell suspension was blocked with HBSS containing 1% FBS (FBS/HBSS), and stained with fluorescently labeled antibodies at 4°C for 30 minutes. After staining, the cell suspension was washed 3 times with HBSS, each followed by centrifugation at 300 *g* at 4°C for 5 minutes. The final cell pellet was resuspended in 1% FBS/HBSS containing 1-μg/mL propidium iodide (Nacalai tesque, Kyoto, Japan; Cat. No. 29037-92). The cell suspension was analyzed using a BD FACSCanto II (BD Biosciences Japan, Tokyo, Japan) and FlowJo software (FlowJo LLC, Ashland, OR).

Quantitative Real-Time Polymerase Chain Reaction {#sec3.7}
------------------------------------------------

A freshly excised mouse stomach was cut into small pieces, which were quickly immersed into 500 μL of RNAlater (Sigma-Aldrich Japan, Tokyo, Japan; Cat. No. R0901-500ML). The stomach tissue was then frozen in liquid N~2~, fractured using an SK-100 mill (Tokken, Inc, Chiba, Japan), and processed for RNA isolation. The total RNA was isolated using an RNeasy Mini Kit (Qiagen, Tokyo, Japan; Cat. No. 74106), and complementary DNA was synthesized using ReverTraAce (Toyobo, Osaka, Japan; Cat. No. TRT-101) according to the manufacturers' instructions. Quantitative RT-PCR (qRT-PCR) was performed using the QuantiTect SYBR Green PCR Kit (Qiagen; Cat. No. 204143), and the 7900HT Fast Real-Time PCR System (Applied Biosystems Japan, Tokyo, Japan). The oligonucleotide sequences for qRT-PCR are listed in [Table 2](#tbl2){ref-type="table"}.Table 2Primer Sequences for Quantitative Real-Time PCRGeneForward primerReverse primer*IL-1b*GCCTCGTGCTGTCGGACCTGTCGTTGCTTGGTTCTCCTTG*TNF-a*AGGCTGCCCCGACTACGTGACTTTCTCCTGGTATGAGATAGCAAA*CXCL1*TGAGCTGCGCTGTCAGTGCCTAGAAGCCAGCGTTCACCAGA*CXCL5*GCATTTCTGTTGCTGTTCACGCTGCCTCCTTCTGGTTTTTCAGTTTAGC*CCL28*GAAGCGCATGGAGCTCTGAAGCTAGGTGGATCTCTGTGAGTTTG*STAT3*GGATCGCTGAGGTACAACCCGTCAGGGGTCTCGACTGTCT*NFkB*GAAATTCCTGATCCAGACAAAAACATCACTTCAATGGCCTCTGTGTAG*IKKb*TTCCAGCTGAGGAAAGTG TGAGCTGTTATTCCGGAGGAGA*ASCL2*GCCTACTCGTCGGAGGAACCAACTGGAAAAGTCAAGCA*TLR2*AACCTCAGACAAAGCGTCAAATCACCAAGATCCAGAAGAGCCAAA*c-Myc*ATGCCCCTCAACGTGAACTTCCGGAGTCGTAGTCGAGGTCATA*HIF2a*TGAGTTGGCTCATGAGTTGCTTGCTGATGTTTTCCGACAG*MMP7*AGGTGTGGAGTGCCAGATGTTGCCACTACGATCCGAGGTAAGTC*sox2*GGCAGCTACAGCATGATGCAGGAGCCTGGTCATGGAGTTGTACTGCAGG*Wnt1*AAATGGCAATTCCGAAACCGAAGATGAACGCTGTTTCTCG*Wnt2*AAATGGCAATTCCGAAACCGAGGTGATTGCGAAGATGAA*Wnt3*AGGAGTGCCAGCATCAGTTCACTTCCAGCCTTCTCCAGGT*Wnt4*CTGGAGAAGTGTGGCTGTGACAGCCTCGTTGTTGTGAAGA*Wnt5*CAAATAGGCAGCCGAGAGACCTCTAGCGTCCACGAACTCC*mCldn-1*CTGGAAGATGATGAGGTGCAGAAGACCACTAATGTCGCCAGACCTGAA*mCldn-2*ATACTACCCTTTAGCCCTGACCGAGACAGTAGGAGCACACATAACAGCTACCAC*mCldn-3*CACCACTACCAGCAGTCGATGAACAGACTGTGTGTCGTCTGTCACCATC*mCldn-4*GGTAGCTCAGCTGTGACTTTGGACTCCTGGAGTAACGTGTAGGCTGAGTGAG*mCldn-5*TAACCTGAAAGGGCAGCTGGAGAAACAGGTCCAGGCTAAGTCCTTTGGTTCAGTAG*mCldn-6*TGCCCACTCTATCATCCAGGACTTCAGGCCTGAGGCTGCCCAG*mCldn-7*ACGCCCATGAACGTTAAGTACGAGCTTTGCTTTCACTGCCTGGACA*mCldn-8*CTGGGGATAAAAGAGAAGGAGGCTGAAGGCTGCAAAGCAGGATAGCAGAAAG*mCldn-9*CTTGAGCTAACCCTCTGTAGTGGTTGCCAGAGTAAGAAAGTCCAGGAGAGCA*mCldn-10.1*TGGGTGCTAGTGTCTTCCACACTGGAATCGGTAACGCAGATCTTCCAC*mCldn-10.2*TCCCACACTTCAAGCCATGAGAGCAGACACTGGACAAAACTTCCAC*mCldn-11*CTGCCGAAAAATGGACGAACTGTGCACGTAGCCTGGAAGGATGA*mCldn-12*CAGACCAGTGTGTACTCAGACTTTCTACCCGAAGCAACATACTGACTGTCTCCTGACG*mCldn-13*GTCAACATCCCAGTATGCAGAGACTTTCGCTGGCCATCAAACATCTAAGGTATC*mCldn-14*GCAGCGTTGATAGCTGAAACTAGGTGCCAAGGCTGCTAGAAACTTTGCTG*mCldn-15*GCAGGGACCCTCCACATACTTGAGTTCATACTTGGTTCCAGCATACAGTG*mCldn-16*CTGGAGGTGAGCACTAAATGCAGAGAGTTACCACCAGCTTCAAGGGATGTTC*mCldn-17*CTTCCACCAGCTACGTCTAAGGCTTACTTCCTGAAGTACTCACAGTTTCTGGGGTGAC*mCldn-18-1.2A*AGTATGAAGGGCTCTGGAGGAGTTGAGAACAATGCCCACGATCATCAG*mCldn-18-2.1A*GTATTCAACTACCAAGGGCTATGGCGTTCATCATCAGGGCTCGTACAGCTTGC*mCldn-19*CAGGTCTCTGTACTTTGACTGCTGTCTCCCAAATTCGTACCTGGCATTGAC*mCldn-20*GGTACACCAAGGAGATCATAGCGAACATGTACAGGGCTCCTCCAGGTTCATA*mClaudin21*CTGGGACTATTGGGACTTCTGAGGAGACTGGAAAGAGGGTAG*mCldn22*CTCCCAGAACGTTCTAATGGGCTTAGAGTGCGGCAAGTAGTTTGTAAGGCAG*mCldn-23*TGGAGTCTGAGGGTGACTTGAACTTCTGAAGGAAGGCTTGACCTCCAGTTAGAGGAAG*mClaudin24*GATCATGGTTCATACCTAGTAAGGACACGACTCGGC*mClaudin25*ACGAGCAGTTCATGGAGAAGCAAAGCACATCAAGCCCAAG*mClaudin26*ATGAACCCTTTCTGGCAGGAACACCATCACGATCAGACTG*mClaudin27*ATCGTATGTGGTTGGGTCTGGGTGTGAGTAGCTGATGTAGATG

POL7085 and Cimetidine Administration {#sec3.8}
-------------------------------------

POL7085 (Polyphor Ltd, Allschwil, Switzerland) (15 mg/kg body weight/250 μL in saline containing 0.03% dimethyl sulfoxide, each day), or cimetidine (Nacalai tesque; Cat. No.09031-14) (20 mg/kg body weight/250 μL in saline containing 0.05% methanol, each day) were intraperitoneally administered to around 50 w.o. mice using a 1-mL syringe (Terumo, Tokyo, Japan; Cat. No. SS-01T) with a 27-gauge needle (Terumo; Cat. No. NN-2719S). Saline containing 0.03% dimethyl sulfoxide or 0.05% methanol was used as the vehicle control. After 1 week of daily administration, the mouse stomach was excised and subjected to qRT-PCR analysis as described above.

Statistical Analysis {#sec3.9}
--------------------

All data were expressed as the mean ± SD. Comparisons between 2 groups were performed using Student's *t* test, and differences with *P \<* .05 were considered statistically significant. Comparisons among more than 3 groups were performed using the Kruskal-Wallis 1-way analysis of variance on ranks (*P \<* .01) followed by the Steel-Dwass test.
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